Hinge Health, Inc. (HNGE)
NYSE: HNGE · Real-Time Price · USD
121.01
-0.71 (-0.58%)
Nov 12, 2026, 2:36 PM EST - Market open
Hinge Health Balance Sheet
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Assets
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 |
|---|---|---|---|---|
Period Ending | Sep '26 Sep 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 |
Cash & Equivalents | 211.55 | 208 | 300.79 | 234.95 |
Short-Term Investments | 83.1 | 155.87 | 165.79 | 188.4 |
Cash & Short-Term Investments | 294.66 | 363.86 | 466.57 | 423.36 |
Cash Growth | -38.62% | -22.01% | 10.21% | - |
Receivables | 148.53 | 66.06 | 42.5 | 46.56 |
Inventory | 19.19 | 15.64 | 10.87 | 13.29 |
Prepaid Expenses | 58.89 | 30.93 | 23.91 | 14.36 |
Other Current Assets | 46.6 | 57.41 | 39.59 | 32.31 |
Total Current Assets | 567.86 | 533.9 | 583.45 | 529.88 |
Property, Plant & Equipment | 47.31 | 17.35 | 16.99 | 22.48 |
Long-Term Investments | 59.54 | 113.17 | - | - |
Goodwill | 113.03 | 64.1 | 61.61 | 61.61 |
Other Intangible Assets | 68.33 | 2.51 | 1.81 | 2.19 |
Long-Term Deferred Tax Assets | - | 1.01 | 1.06 | 0.47 |
Long-Term Deferred Charges | - | 9.65 | 5.46 | 1.92 |
Other Long-Term Assets | 18.01 | 3.08 | 2.89 | 3.99 |
Total Assets | 874.08 | 744.76 | 673.26 | 622.53 |
Liabilities
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 |
|---|---|---|---|---|
Period Ending | Sep '26 Sep 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 |
Accrued Expenses | - | 44.87 | 23.32 | 25.67 |
Current Portion of Leases | 4.72 | 4.22 | 3.81 | 4.64 |
Current Income Taxes Payable | - | 6.17 | 2.12 | 8.2 |
Current Unearned Revenue | 459.17 | 300.86 | 217.63 | 140.47 |
Other Current Liabilities | - | 6.3 | 2.41 | 5.17 |
Total Current Liabilities | 544.71 | 362.41 | 249.3 | 184.16 |
Long-Term Leases | 29.16 | 3.82 | 7.26 | 11.1 |
Total Liabilities | 574.66 | 366.23 | 256.56 | 195.25 |
Shareholders' Equity
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 |
|---|---|---|---|---|
Period Ending | Sep '26 Sep 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 |
Additional Paid-In Capital | 1,215 | 1,230 | 88.1 | 86.75 |
Retained Earnings | -914.78 | -1,051 | -522.74 | -510.8 |
Comprehensive Income & Other | -0.92 | -0.02 | 0.07 | 0.06 |
Total Common Equity | 299.42 | 178.66 | -434.57 | -423.99 |
Shareholders' Equity | 299.42 | 378.54 | 416.7 | 427.28 |
Total Liabilities & Equity | 874.08 | 744.76 | 673.26 | 622.53 |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 |
|---|---|---|---|---|
Period Ending | Sep '26 Sep 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 |
Total Debt | 33.88 | 8.04 | 11.07 | 15.73 |
Net Cash (Debt) | 320.32 | 469 | 455.5 | 407.62 |
Net Cash Growth | -34.10% | 2.96% | 11.74% | - |
Net Cash Per Share | 3.82 | 8.59 | 33.60 | 31.31 |
Filing Date Shares Outstanding | 80.87 | 78.76 | 16.38 | 15.96 |
Total Common Shares Outstanding | 80.87 | 79.17 | 16.38 | 15.96 |
Working Capital | 23.15 | 171.5 | 334.15 | 345.73 |
Book Value Per Share | 3.70 | 2.26 | -26.53 | -26.57 |
Tangible Book Value | 118.06 | 112.05 | -497.98 | -487.79 |
Tangible Book Value Per Share | 1.46 | 1.42 | -30.40 | -30.57 |
Machinery | - | 7.58 | 7.26 | 7.05 |
Leasehold Improvements | - | 0.2 | 0.2 | 0.2 |